Target intelligence / Profile preview

Dynactin subunit 6 (DCTN6)

Target
DCTN6
Molecular classification
Dynactin subunit, Cytoskeletal protein complex component, Other (cargo adaptor, dynein activator), Not classified as receptor, enzyme, transporter, or ion channel
01

Overview

Dynactin subunit 6 (DCTN6) is a protein that forms part of the dynactin complex, a key activator of the molecular motor cytoplasmic dynein, responsible for retrograde transport along microtubules and intracellular trafficking of organelles and protein cargoes. DCTN6 contains an RGD (Arg-Gly-Asp) motif in its N-terminal region, conferring adhesive properties and potential interactions with extracellular matrix proteins like fibronectin. In neurons, DCTN6 interacts with the endoplasmic reticulum and mediates retrograde transport; deficiency impairs ER dynamics and leads to dystrophic neurite formation, a feature linked to aging and Alzheimer’s disease. DCTN6 also regulates Golgi organization and is required for appropriate endo-lysosomal trafficking, partly by interacting with other membrane proteins. It serves as a binding partner for viral proteins (such as classical swine fever virus glycoprotein E2), supporting aspects of viral replication. DCTN6 mRNA expression carries prognostic significance in some cancers. The human protein is encoded by the DCTN6 gene on chromosome 8 and has high sequence conservation with mouse homologs, although its precise molecular roles are still being defined.

Other names
DCTN6Dynactin subunit 6WS3Dynactin subunit p27p27Protein WS-3Dynactin 6Novel RGD-containing protein
02

Mechanism of action

Not directly targeted by drugs; generally acts by mediating dynein activation and directing cargo binding for vesicular transport. Perturbations (knockdown, CRISPR) change expression profiles in transcriptomics screening datasets.

03

Biological functions

Intracellular traffickingRetrograde transport of endoplasmic reticulum in neuronsOrganelle positioning, especially Golgi ribbon organizationEndo-lysosomal machinery regulationDynein-mediated microtubule-based cargo movementAdhesion via RGD motifMitochondrial biogenesis (suggested)
04

Disease associations

Neurodegenerative disease (Alzheimer’s disease, aging-associated neurite pathology)Cancer (biomarker role in ovarian cancer and cutaneous melanoma prognosis)Genetic disorder (associated with nonsyndromic deafness, Charcot-Marie-Tooth disease)Infection (co-opted by classical swine fever virus for replication)Other (general membrane trafficking disorders)
05

Safety considerations

No direct safety or therapeutic toxicity concerns reportedPotential risk for off-target effects if therapeutic modulation of dynein/dynactin complex attempted (inferred based on cytoskeleton disruption/human disease association)
06

Interacting drugs

None directly listed or well established in current resources

1 more in the full profile.

07

Biomarkers

High DCTN6 mRNA expression used for prognosis in ovarian cancer and cutaneous melanoma (favorable marker)No clinically validated companion diagnostics

Beyond the preview

Go deeper on Dynactin subunit 6 (DCTN6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dynactin subunit 6 (DCTN6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call